Premier Integrated Labs is leading efforts to advance early diagnosis and understanding of Alzheimer’s disease in Malaysia – a critical step in improving outcomes for patients and families affected by the condition.
On 22 April 2025, Premier Integrated Labs (PIL) launched a nationwide Continuing Medical Education tour in Penang, in collaboration with Mayo Clinic Laboratories and Eisai Co., Ltd.
The inaugural event brought together neurology specialists from both public and private hospitals to spotlight the importance of early detection and biomarker-based testing for Alzheimer’s.
Dr Jaron L from Mayo Clinic Laboratories highlighted the benefits of biomarker-driven diagnostics, while Dr Yew Keong Ng from Eisai shared insights into the evolving diagnostics landscape in Malaysia. The strong turnout underscored the clinical community’s shared commitment to tackling one of the most pressing neurological challenges of our time.
Separately, PIL also participated in a strategic session with YBhg Datuk Dr Muhammad Radzi Abu Hassan, former Director-General of Health, Malaysia Ministry of Health, to present updates on the ongoing study “Whole Exome Sequencing in Late-Onset Alzheimer’s Disease (LOAD) in Peninsular Malaysia.” The study seeks to uncover genomic markers and better understand the clinical characteristics of LOAD among local patients.
Representing PIL were CEO Hareeff Muhammed, Sayyidi Hamzi, and Dr Zubaidah, alongside collaborators Dr Hans Prakash (Institute for Medical Research) and Dr Cheah Wee Kooi (Hospital Taiping).
These initiatives reflect PIL’s dedication to fostering clinical collaboration, advancing diagnostics, and driving evidence-based care in the fight against Alzheimer’s disease.
Related Stories
Premier Integrated Rehab Marks 25 Years with a Renewed Commitment to Rehab Care
Premier Integrated Rehab has embarked on a new chapter in its journey, unveiling a refreshed brand identity in celebration of its 25th anniversary.
Gleneagles Hospital Hong Kong Forms Strategic Partnerships to Advance AI-Driven Healthcare & Diagnostic Innovation
Gleneagles Hospital Hong Kong has entered into two significant collaborations aimed at enhancing patient care through advanced technology and diagnostics.
Fortis Healthcare Opens Super-Specialty Outpatient Clinic for Advanced Medical Care
Fortis Healthcare has opened a dedicated super-specialty outpatient (OPD) clinic in Guwahati, aimed at improving access to advanced medical care for residents of the city and surrounding areas.
Championing Cross-Country Care at the Asia Summit on Global Health
Gleneagles is proud to mark its fifth consecutive year as the Future Private Health Partner at the Asia Summit on Global Health (ASGH).
Fortis Hospital Bengaluru Partners Teleflex to Advance Urology Innovation
Fortis Hospital Bengaluru has signed a Memorandum of Understanding with Teleflex, a global medical technology company, to set up the UroLift® Centre of Education for South Asia, the first of its kind in the region.
-(11).png?sfvrsn=660b02e5_1)
Fortis Hospital Vasant Kunj Launches Dedicated Obesity Clinic to Tackle India’s Growing Health Challenge
Fortis Hospital Vasant Kunj has taken a significant step forward in addressing India’s obesity epidemic by offering comprehensive, multidisciplinary care.
